UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016782 |
|---|---|
| Receipt number | R000019475 |
| Scientific Title | An exploratory study of treatment sensitivity and prognostic factors in a Phase III, randomized, controlled study comparing the efficacy and safety of mFOLFOX6 + bevacizumab therapy vs. mFOLFOX6 + panitumumab therapy in patients with chemotherapy-naïve wild-type RAS(KRAS/NRAS) unresectable advanced or recurrent colorectal cancer |
| Date of disclosure of the study information | 2015/03/23 |
| Last modified on | 2024/03/18 10:05:29 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/03/11 18:58:19 | ||
| 2 | Update | 2015/03/24 10:22:51 | Last name of contact person Last name of contact person Division name Address Name of person sending information Name of person sending information |
|
| 3 | Update | 2015/03/24 10:24:27 | Email |
|
| 4 | Update | 2015/06/16 12:10:19 | Recruitment status |
|
| 5 | Update | 2015/10/15 19:17:36 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Study ID_2 Org. issuing International ID_2 Org. issuing International ID_2 |
|
| 6 | Update | 2016/09/12 09:04:56 | Name of primary person or sponsor Organization |
|
| 7 | Update | 2017/06/14 19:06:42 | Recruitment status |
|
| 8 | Update | 2020/03/13 14:05:25 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Address Address TEL Zip code Organization1 Address1 Tel1 Organization Organization Address Address Tel |
|
| 9 | Update | 2020/05/21 17:02:40 | Date of IRB Last follow-up date |
|
| 10 | Update | 2021/03/15 09:20:23 | Number of participants that the trial has enrolled |
|
| 11 | Update | 2021/03/15 09:42:17 | Number of participants that the trial has enrolled |
|
| 12 | Update | 2021/06/15 14:30:18 | Last follow-up date |
|
| 13 | Update | 2022/03/15 13:58:24 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 14 | Update | 2023/09/20 09:04:32 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 15 | Update | 2024/03/18 09:40:00 | Recruitment status |
|
| 16 | Update | 2024/03/18 09:48:44 | URL releasing protocol Publication of results URL related to results and publications Results Results |
|
| 17 | Update | 2024/03/18 10:05:29 | Email Email1 |
